Cowen and Company’s Relmada Therapeutics RLMD Stock Holding History

Cowen and Company’s Portfolio RLMD Stock Details RLMD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$223K	Sell
2022 Q3	$8.01M	Sell
2022 Q2	$20.3M	Sell
2022 Q1	$31.4M	Buy
2021 Q4	$3.37M	Sell
2021 Q3	$4.18M	Hold
2021 Q2	$5.11M	Sell
2021 Q1	$5.88M	Buy